KTTA - Pasithea stock soars as high as 190% on preclinical data December, 11 2023 11:15 AM Pasithea Therapeutics Corp. 2023-12-11 11:15:05 ET More on Pasithea Therapeutics Pasithea stock jumps 12% on update for anti-tumor drug PAS-004 Financial information for Pasithea Therapeutics For further details see: Pasithea stock soars as high as 190% on preclinical data